Stock DNA GINKGO BIOWORKS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Delayed Nyse
Other stock markets
 01:00:01 2024-07-03 pm EDT 		5-day change 1st Jan Change
0.3755 USD +8.37% Intraday chart for Ginkgo Bioworks Holdings, Inc. +32.26% -77.78%
Jun. 28 Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3% MT
May. 30 Transcript : Ginkgo Bioworks Holdings, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%
MT
Ginkgo Bioworks Gets NYSE Noncompliance Notice on Minimum Closing Price
MT
Ginkgo Bioworks Holdings Q1 Loss Narrows, Revenue Drops; 2024 Revenue Outlook Slashed; Cost Cuts Planned
MT
Ginkgo Bioworks Holdings, Inc. Updates Revenue Guidance for the Full Year 2024
CI
Earnings Flash (DNA) GINKGO BIOWORKS Posts Q1 Revenue $38M, vs. Street Est of $46M
MT
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ginkgo Bioworks, GreenLab Launch Partnership to Produce Sugar Substitute Brazzein
MT
GreenLab and Ginkgo Bioworks Announce New Partnership
CI
Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
CI
Ginkgo Bioworks Acquires AgBiome's Platform Assets
MT
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk
MT
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil
MT
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
CI
Ginkgo Bioworks, Prozomix Collaborate on Enzyme Development
MT
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
CI
Ginkgo Bioworks (NYSE: DNA) completed the acquisition of cell therapy platform assets of Modulus Therapeutics.
CI
Ginkgo Bioworks Awarded $6 Million DARPA Contract to Work on Cold-Weather Applications for Military and Commercial Use
MT
Ginkgo Bioworks Wins DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
CI
AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production
CI
Ginkgo Bioworks, Imagindairy to Develop Animal-Free Dairy Proteins
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DNA Stock
  4. News Ginkgo Bioworks Holdings, Inc.
  5. Highlights